Caricamento...
Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
Migraine is a very disabling disorder with severe impact on patients’ lives and substantive costs to society in terms of healthcare costs and lost productivity. Prevention is a key component of migraine therapy, and while numerous preventive options exist, each is burdened by either troublesome side...
Salvato in:
Pubblicato in: | Curr Treat Options Neurol |
---|---|
Autori principali: | , |
Natura: | Artigo |
Lingua: | Inglês |
Pubblicazione: |
Springer US
2017
|
Soggetti: | |
Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5486583/ https://ncbi.nlm.nih.gov/pubmed/28653227 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11940-017-0463-4 |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|